Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.

The long-term hematological response in a patient with 5q- syndrome after lenalidomide suspension and the further improvement observe while she was receiving deferasirox alone is reported.

Saved in:
Bibliographic Details
Main Author: Pasquale Niscola
Format: Article
Language:English
Published: PAGEPress Publications 2014-08-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://mjhid.org/index.php/mjhid/article/view/1921
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846098394274070528
author Pasquale Niscola
author_facet Pasquale Niscola
author_sort Pasquale Niscola
collection DOAJ
description The long-term hematological response in a patient with 5q- syndrome after lenalidomide suspension and the further improvement observe while she was receiving deferasirox alone is reported.
format Article
id doaj-art-24b7b1b4dbb2424b96f9bd6dc10ae438
institution Kabale University
issn 2035-3006
language English
publishDate 2014-08-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-24b7b1b4dbb2424b96f9bd6dc10ae4382025-01-02T00:30:30ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062014-08-011Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.Pasquale Niscola0Pasquale Niscola, MD PhD, Hematology Unit, S. Eugenio Hospital, Rome (Italy) T: +390651003241 F: +390651003245 pniscola@gmail.com.The long-term hematological response in a patient with 5q- syndrome after lenalidomide suspension and the further improvement observe while she was receiving deferasirox alone is reported.https://mjhid.org/index.php/mjhid/article/view/1921chromosome 5q deletiondeferasiroxlenalidomidemyelodysplastic syndrome (MDS).
spellingShingle Pasquale Niscola
Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
Mediterranean Journal of Hematology and Infectious Diseases
chromosome 5q deletion
deferasirox
lenalidomide
myelodysplastic syndrome (MDS).
title Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
title_full Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
title_fullStr Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
title_full_unstemmed Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
title_short Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
title_sort long term hematological response in 5q syndrome after lenalidomide suspension and further improvement by deferasirox
topic chromosome 5q deletion
deferasirox
lenalidomide
myelodysplastic syndrome (MDS).
url https://mjhid.org/index.php/mjhid/article/view/1921
work_keys_str_mv AT pasqualeniscola longtermhematologicalresponsein5qsyndromeafterlenalidomidesuspensionandfurtherimprovementbydeferasirox